Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Aurora Cannabis

Cara Therapeutics

Canopy Growth

GW Pharmaceuticals

HEXO Corp

OrganiGram Holdings Inc.

Tilray Brands

Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.
The post 10 Marijuana Stocks That Could See 100% Gains, If Not More appeared first on InvestorPlace.

10 Marijuana Stocks That Could See 100% Gains, If Not More

The cannabis sector is poised to break out of the summer doldrums -- and CRON stock will lead the charge.
The post Watch Cronos Stock Continue to Grow Over the Coming Weeks appeared first on InvestorPlace.

Watch Cronos Stock Continue to Grow Over the Coming Weeks

These cannabis stocks all offer at least 36% upside.

3 Marijuana Stocks You Should Buy, According to This 124-Year-Old Wall Street Firm

Here's what needs to happen if these marijuana stocks are going to come bouncing back.

Have These Tumbling Cannabis Stocks Hit Bottom Yet?

This high-yield dividend stock should outperform during a market downturn.

1 Rock-Solid Marijuana Stock to Buy in a Recession

Green Thumb Industries Inc.

Piper Jaffray likes several U.S. cannabis stocks and one Canadian pot stock better than Aurora.

Forget Aurora Cannabis, a Top Analyst Says Buy These 5 Pot Stocks Instead

CRON stock is not without its risks. But recent bullish commentary from Piper Jaffray highlights all the reasons long-term investors may need to take a closer look at Cronos.

3 Reasons to Love Cronos Stock

Cannabis stocks got a boost on Tuesday after a major Wall Street firm initiated bullish coverage of Cronos Group Inc (NASDAQ: CRON).

Piper Jaffray Initiates Coverage Of Cronos, Says Stock 'Warrants A Premium Valuation'

Because marijuana investments like Cronos Group stock are so sensitive to news items, they’re prone to severe volatility. However, the opposite is also true, which makes this discounted price point a compelling proposition.

Narrative-Driven Cronos Group Stock Finally Has Good News

Altria

I wouldn’t be surprised if the recent $300 million purchase of Los Angeles-based Redwood Holding Group, a manufacturer of hemp-derived cannabidiol (CBD) infused skincare and other hemp-derived products, was an idea hatched by Altria. 
The post Cronos Stock Still Looks Like a Brilliant Investment for Altria appeared first on InvestorPlace.

Cronos Stock Still Looks Like a Brilliant Investment for Altria

It was a rough month for marijuana stocks.

Why Aurora Cannabis, Cronos Group, and Canopy Growth Plunged in July

Aphria

Each of these seven marijuana stocks can teach a valuable lesson into how to use technical analysis to identify important levels.

Marijuana Stocks With Critical Levels to Watch

Marijuana stock investor have been dealing with negative investor sentiment for several months now. However, a new Cronos CBD deal and a huge positive reaction to Aphria earnings may have turned the tide.

Cronos and Aphria Stock Shift Marijuana Investing Sentiment

Is  (CRON) Outperforming Other Finance Stocks This Year?

Has Cronos Group (CRON) Outpaced Other Finance Stocks This Year?

Cronos Group may have blown Wall Street's forecasts out of the water, but that doesn't tell the full story.

Sorry, Folks, but Cronos Group's Second-Quarter Results Aren't That Impressive

Cronos Group's latest results don't have implications just for Cronos.

3 Details in Cronos Group's Q2 Results That Impact All Canadian Cannabis Stocks

Advanced Micro Devices

Uber

Kraft Heinz

Microsoft

Uber, Microsoft, AMD, Kraft Heinz and Cronos Group are our top stock trades. Here's how to trade them now.

5 Top Stock Trades for Friday (Aug 09)

The cannabis company more than triples its revenue figure.

Cronos Group's Q2 Trounces Estimates

Cronos Group Inc. (CRON) CEO Mike Gorenstein on Q2 2019 Results - Earnings Call Transcript

Shares of Cronos Group Inc (NASDAQ: CRON) traded higher Thursday morning after the cannabis company reported a four-fold jump in revenue year-over-year in its second quarter results.

Cronos Group Trades Higher After Revenue Jumps Three-Fold In Q2

Canadian cannabis company Cronos Group Inc.'s shares CRON, +4.49% CRON, +3.81% rose 8% in premarket trade Thursday, after the company posted stronger-than-expected earnings for the second quarter.

Canadian cannabis company Cronos stock soars 8% premarket after earnings beat

Cronos Group earnings: A Q2 profit defied views for a slim loss. Revenue tripled.

Cronos Group Earnings Surprise As Revenue Triples; Marijuana Stock Jumps

The U.S. is where the big money will be made in cannabis.

3 Canadian Cannabis Stocks With the Best U.S. Strategies

Investors will focus on Cronos' (CRON) regular top and bottom-line numbers along with its pipeline progress when it reports second-quarter results.

Cronos (CRON) to Report Q2 Earnings: What's in the Cards?

Cronos Group just did something that no major cannabis stock has done before.

News for Cronos Group Stock (CRON)